| [1] |
Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future[J]. Ann Surg, 2011, 253(3):453-469.
|
| [2] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
| [3] |
Songserm N, Promthet S, Sithithaworn P, et al. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms[J]. Cancer Epidemiol, 2012, 36(2):e89-94.
|
| [4] |
Sriraj P, Aukkanimart R, Boonmars T, et al. Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma?[J]. Parasitol Res, 2013, 112(8):2971-2981.
|
| [5] |
Wadsworth CA, Westaby D, Khan SA. Endoscopic radiofrequency ablation for cholangiocarcinoma[J]. Curr Opin Gastroenterol, 2013, 29(3):305-311.
|
| [6] |
Sripa B, Brindley PJ, Mulvenna J, et al. The tumorigenic liver fluke Opisthorchis viverrini: multiple pathways to cancer[J]. Trends Parasitol, 2012, 28(10):395-407.
|
| [7] |
Sripa B, Thinkhamrop B, Mairiang E, et al. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini[J]. PLoS Negl Trop Dis, 2012, 6(5):e1654.
|
| [8] |
Sawanyawisuth K, Wongkham C, Araki N, et al. Serial analysis of gene expression reveals promising therapeutic targets for liver fluke-associated cholangiocarcinoma[J]. Asian Pac J Cancer Prev, 2012, 13 Suppl:89-93.
|
| [9] |
Jinawath N, Chamgramol Y, Furukawa Y, et al. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma[J]. Hepatology, 2006, 44(4):1025-1038.
|
| [10] |
Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels[J]. Nature, 2010, 466(7308):835-840.
|
| [11] |
Sawanyawisuth K, Silsirivanit A, Kunlabut K, et al. A novel carbohydrate antigen expression during development of Opisthorchis viverrini-associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis[J]. Parasitol Int, 2012, 61(1):151-154.
|
| [12] |
Chusorn P, Namwat N, Loilome W, et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis[J]. Tumour Biol, 2013, 34(3):1579-1588.
|
| [13] |
Ong CK, Subimerb C, Pairojkul C, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma[J]. Nat Genet, 2012, 44(6):690-693.
|
| [14] |
Chan-On W, Nairismagi ML, Ong CK, et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers[J]. Nat Genet, 2013, 45(12):1474-1478.
|
| [15] |
Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology[J]. Nat Med, 2011, 17(3):330-339.
|
| [16] |
Plongthongkum N, Diep DH, Zhang K. Advances in the profiling of DNA modifications: cytosine methylation and beyond[J]. Nat Rev Genet, 2014, 15(10):647-661.
|
| [17] |
Sriraksa R, Zeller C, El-Bahrawy MA, et al. CpG-island methylation study of liver fluke-related cholangiocarcinoma[J]. Br J Cancer, 2011, 104(8):1313-1318.
|